BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)

CUSIP: 09058V103

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Common Stock
Shares outstanding
210,587,372
Total 13F shares
98,732,839
Share change
-1,455,643
Total reported value
$282,887,178
Put/Call ratio
13%
Price per share
$2.86
Number of holders
110
Value change
-$6,967,337
Number of buys
52
Number of sells
52

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAKER BROS. ADVISORS LP
13F
Company
6.8%
14,382,673
$54,510,000 30 Jun 2019
13F
JANUS HENDERSON GROUP PLC
13F
Company
4.6%
9,596,344
$36,370,000 30 Jun 2019
13F
BlackRock Finance, Inc.
13F
Company
4.2%
8,925,891
$33,831,000 30 Jun 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
3.4%
7,096,297
$26,895,000 30 Jun 2019
13F
VANGUARD GROUP INC
13F
Company
3.2%
6,692,444
$25,365,000 30 Jun 2019
13F
STATE STREET CORP
13F
Company
3.2%
6,645,717
$25,187,000 30 Jun 2019
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
3%
6,292,980
$23,850,000 30 Jun 2019
13F
CITADEL ADVISORS LLC
13F
Company
1.7%
3,492,598
$13,237,000 30 Jun 2019
13F
FMR LLC
13F
Company
1.4%
2,894,741
$10,971,000 30 Jun 2019
13F
VHCP Management II, LLC
13F
Company
1.4%
2,874,602
$10,895,000 30 Jun 2019
13F
VHCP Management III, LLC
13F
Company
1.3%
2,708,207
$10,264,000 30 Jun 2019
13F
Ghost Tree Capital, LLC
13F
Company
1.2%
2,500,000
$9,475,000 30 Jun 2019
13F
Schonfeld Strategic Advisors LLC
13F
Company
1.1%
2,233,700
$8,467,000 30 Jun 2019
13F
UBS Group AG
13F
Company
1%
2,202,794
$8,349,000 30 Jun 2019
13F
D. E. Shaw & Co., Inc.
13F
Company
0.71%
1,491,354
$5,652,000 30 Jun 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.71%
1,486,599
$5,634,000 30 Jun 2019
13F
Invesco Ltd.
13F
Company
0.69%
1,446,672
$5,483,000 30 Jun 2019
13F
MORGAN STANLEY
13F
Company
0.67%
1,412,653
$5,354,000 30 Jun 2019
13F
NORTHERN TRUST CORP
13F
Company
0.65%
1,363,049
$5,165,000 30 Jun 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.48%
1,005,707
$3,812,000 30 Jun 2019
13F
Nuveen Asset Management, LLC
13F
Company
0.39%
818,233
$3,101,000 30 Jun 2019
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.31%
652,733
$2,474,000 30 Jun 2019
13F
EMORY UNIVERSITY
13F
Company
0.31%
645,583
$2,447,000 30 Jun 2019
13F
FEDERATED HERMES, INC.
13F
Company
0.29%
608,316
$2,306,000 30 Jun 2019
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.27%
566,169
$2,146,000 30 Jun 2019
13F
Sio Capital Management, LLC
13F
Company
0.25%
522,863
$1,982,000 30 Jun 2019
13F
University Of Notre Dame du Lac
13F
Individual
0.23%
489,196
$1,854,000 30 Jun 2019
13F
FIRST MIDWEST BANK TRUST DIVISION
13F
Company
0.22%
472,604
$1,791,000 30 Jun 2019
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.22%
454,699
$1,724,000 30 Jun 2019
13F
Bank of New York Mellon Corp
13F
Company
0.21%
452,282
$1,714,000 30 Jun 2019
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.21%
439,612
$1,666,000 30 Jun 2019
13F
Sofinnova Investments, Inc.
13F
Company
0.2%
426,400
$1,616,000 30 Jun 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.2%
421,933
$1,599,000 30 Jun 2019
13F
DAFNA Capital Management LLC
13F
Company
0.2%
410,888
$1,557,000 30 Jun 2019
13F
Rafferty Asset Management, LLC
13F
Company
0.18%
380,494
$1,442,000 30 Jun 2019
13F
CITIGROUP INC
13F
Company
0.18%
379,648
$1,439,000 30 Jun 2019
13F
BARCLAYS PLC
13F
Company
0.17%
360,837
$1,368,000 30 Jun 2019
13F
Eversept Partners, LP
13F
Company
0.16%
342,460
$1,297,923 30 Jun 2019
13F
Capital World Investors
13F
Company
0.16%
341,321
$1,294,000 30 Jun 2019
13F
JPMORGAN CHASE & CO
13F
Company
0.14%
298,597
$1,084,000 30 Jun 2019
13F
Allianz Asset Management GmbH
13F
Company
0.13%
265,144
$1,005,000 30 Jun 2019
13F
DEUTSCHE BANK AG\
13F
Company
0.11%
237,089
$896,000 30 Jun 2019
13F
PREMIER ASSET MANAGEMENT LLC
13F
Company
0.09%
192,765
$730,000 30 Jun 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.09%
183,419
$695,000 30 Jun 2019
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.08%
168,289
$638,000 30 Jun 2019
13F
RHUMBLINE ADVISERS
13F
Company
0.08%
161,431
$612,000 30 Jun 2019
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.07%
152,600
$578,000 30 Jun 2019
13F
ClariVest Asset Management LLC
13F
Company
0.07%
150,998
$572,000 30 Jun 2019
13F
CREDIT SUISSE AG/
13F
Company
0.07%
148,000
$560,000 30 Jun 2019
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.07%
141,020
$534,000 30 Jun 2019
13F

Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q3 2019

As of 30 Sep 2019, BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 98,732,839 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, BlackRock Inc., JANUS HENDERSON GROUP PLC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, STATE STREET CORP, CITADEL ADVISORS LLC, Point72 Asset Management, L.P., UBS Group AG, and VHCP Management II, LLC. This page lists 110 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders
112
Q3 2019 holders
110
Holder diff
-2
Investor Q2 2019 Shares Q3 2019 Shares Share Diff Share Chg % Q2 2019 Value $ Q3 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.